ANGELA WILSON: Open Payments
NPI 1225652191 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,184 in 110 payments from 16 companies in 2025. Trend: 2023 $2,170 · 2024 $3,009 · 2025 $2,184
Food & beverage: $2,184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $344 |
| Alkermes, Inc. | 17 | $280 |
| Collegium Pharmaceutical, Inc. | 15 | $235 |
| Otsuka America Pharmaceutical, Inc. | 11 | $233 |
| Janssen Pharmaceuticals, Inc | 4 | $214 |
| Neurocrine BioSciences, Inc. | 7 | $184 |
| E.R. Squibb & Sons, L.L.C. | 11 | $176 |
| Lundbeck LLC | 11 | $151 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $80 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
Products named: VRAYLAR, REXULTI, ARISTADA, Jornay PM, INGREZZA, COBENFY, SPRAVATO, ABILIFY ASIMTUFII.
Industry payments across NV — which companies pay providers there.
